Transitioning HIV+ Adolescents to Adult Care: Exploring Adolescent and Adult Medicine Clinics Role in the Process

Sponsor
University of North Carolina, Chapel Hill (Other)
Overall Status
Completed
CT.gov ID
NCT02785302
Collaborator
National Institute on Drug Abuse (NIDA) (NIH), National Institute of Mental Health (NIMH) (NIH)
136
14
15
9.7
0.6

Study Details

Study Description

Brief Summary

This is a multi-site, longitudinal study and it describes the transition process of behaviorally-infected HIV-positive youth as they move from pediatric- and adolescent-specific care to adult care. To achieve this goal, the transition process is characterized from the perspectives of HIV-positive youth, Adolescent Medicine Trials Unit (AMTU) clinic staff, and receiving adult clinic staff.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    The changes associated with transition to adult clinical care may increase the likelihood that an adolescent will drop out of care, which results in poorer outcomes. Disengagement from care has implications for health. Disruption in medication can increase viral load (VL), and intensify the potential for co-morbidities and transmission efficiency . Thus, successful transition to adult care is especially important for HIV-positive adolescents (compared to other chronic diseases) as they will need to maintain clinic visits and medication adherence across their lifespan to remain healthy and maintain a low VL to reduce the potential for transmission in the context of other developmental and psychosocial changes and challenges. The ultimate goal of this study is to represent the key places - youth, adolescent clinic and adult clinic - where transition interventions could be targeted and to collect data to capture the key elements and modifiable variables at each level. This study will contribute to existing research by providing transition research on HIV, which differs from other congenital or acquired chronic conditions due to it being an infectious disease; by prospectively following youth as they transition; and by providing transition research from the perspective of receiving adult clinics. It will also illustrate how each level- youth, adolescent clinic and adult clinic - is situated within a specific context and how these levels interact to affect transition outcomes.

    This is a multi-method, longitudinal design research study. Subjects must be enrolled in ATN 125 at the time of the ATN 135 baseline visit. There will be no randomization procedures. During the 39-week study, surveys will be administered to adolescents and young adults transitioning to adult care via Audio Computer Assisted Self Interviews (ACASIs), which will collect data on individual (e.g., psychosocial and behavioral) and clinical factors affecting transition at 0 and 39 weeks. Demographic, biomedical, antiretroviral therapy (ART) and healthcare utilization visit information collected through ATN 125 medical chart abstraction will also become part of the ATN 135 subject dataset. One-time phone surveys and interviews with AMTU and adult clinic staff will also be conducted to collect information on transition protocols as well as review of any documentation of existing transition protocols (e.g., transitioning SOP). Outcome measures will include pre- and post-transition VL and other measures of physical and psychosocial health status to compare individuals with different patterns and outcomes of transition.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    136 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    CATCH: Comprehensive Assessment of Transition and Coordination for HIV-Positive Youth as They Move From Adolescent to Adult Care
    Study Start Date :
    Aug 1, 2015
    Actual Primary Completion Date :
    Nov 1, 2016
    Actual Study Completion Date :
    Nov 1, 2016

    Arms and Interventions

    Arm Intervention/Treatment
    Adolescents and Young Adults:

    Behaviorally-infected, HIV-positive, adolescents and young adults enrolled in ATN 125, aged 18 through 24, inclusive who are transition eligible. All subjects with available endpoint data will be included in the analysis.

    AMTU and Adult Clinic Staff

    Clinical staff at the Adolescent Medical Trials Units (AMTUs) and at adult clinics where the AMTUs refer their transitioning patients will be recruited to complete quantitative surveys and semi-structured interviews.

    Outcome Measures

    Primary Outcome Measures

    1. Transition Expectations and Experiences as assessed by the ACASI (comparison between pre- and post-transition) [Baseline]

    2. Transition Expectations and Experiences as assessed by the ACASI (comparison between pre- and post-transition) [39 weeks]

    3. Patterns of Transition as assessed by the ACASI, as well as medical and appointment records abstraction (comparison between pre- and post-transition) [Baseline]

    4. Patterns of Transition as assessed by the ACASI, as well as medical and appointment records abstraction (comparison between pre- and post-transition) [39 weeks]

    5. Patterns of Engagement in Care as assessed by the ACASI, as well as medical and appointment records abstraction (assessment over time from point of transition) [Baseline]

    6. Patterns of Engagement in Care as assessed by the ACASI, as well as medical and appointment records abstraction (assessment over time from point of transition) [39 weeks]

    Secondary Outcome Measures

    1. Transition Protocols at AMTUs and Adult Clinics [1 day]

      Transition protocols will be assessed by one-time interviews with AMTU Clinic staff where youth from AMTUs transition their care within one year of site registration.

    2. Transition Processes at AMTUs and Adult Clinics [1 day]

      Transition processes will be assessed by one-time interviews with AMTU Clinic staff where youth from AMTUs transition their care within one year of site registration.

    3. Preparedness of Adult Clinics to Receive Behaviorally-Infected HIV-Positive Youth Transitioning from Adolescent Clinics [1 day]

      Preparedness will be assessed by one-time interviews with Adult Clinic staff where youth from AMTUs transition their care within one year of site registration.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 24 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes

    Adolescents and young adults

    Inclusion Criteria

    To be considered eligible to participate in 135, behaviorally-infected HIV-positive adolescents and young adults must be:

    • Enrolled in ATN 125

    • Be transition eligible. Transition eligible means that the youth are either (a) age 18 through 24 years old and planning to transition to adult medical care within six months after ATN 135 enrollment or (b) 24 years old and not actively planning to transition to adult medical care.

    • Willing and able to provide consent to participate.

    Exclusion Criteria

    To be considered eligible for enrollment, an individual must not meet any of the criteria listed below.

    • Presence of serious psychiatric symptoms (e.g., active hallucinations, thought disorder) that would impair the individual's ability to provide true informed consent or participate in the baseline ACASI;

    • Visibly distraught (e.g., suicidal, homicidal, exhibiting violent behavior) at the time of consent or the baseline ACASI;

    • At the time of consent, intoxicated or under the influence of alcohol or other substances to such an extent that in the opinion of the study staff, the ability to give true informed consent is impaired; or

    • At the time of the baseline ACASI, intoxicated or under the influence of alcohol or other substances to such an extent that in the opinion of the study staff, the subject's ability to understand and answer the questions may be impaired and negatively impact the integrity of the research data.

    AMTU and Partner Adult Clinic Staff

    To be considered eligible to complete the AMTU and partner adult clinic surveys and semi-structured interviews, an individual must meet all of the criteria listed below.

    • Being a clinical staff (e.g., healthcare providers, social workers, case managers, transition person) at either an AMTU or AMTU-affiliated site or partner adult clinic;

    • Supporting (in any capacity) transition efforts for HIV-positive adolescents; and

    • Willing and able to provide verbal consent for surveys and semi-structured interviews.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Childrens Hospital of Los Angeles Los Angeles California United States 90027
    2 University of Colorado - The Children's Hospital of Denver Aurora Colorado United States 80045
    3 Children's Hosp Natinal Med Center Washington District of Columbia United States 20010
    4 University of Miami Miami Florida United States 33101
    5 University of South Florida Tampa Florida United States 33606
    6 Stroger Hospital of Cook County Chicago Illinois United States 60612
    7 Tulane Medical Center New Orleans Louisiana United States 70112
    8 Johns Hopkins University Baltimore Maryland United States 21287
    9 Fenway Institute Boston Massachusetts United States 02215
    10 Wayne State University Detroit Michigan United States 48201
    11 Montefiore Medical Center Bronx New York United States 10467
    12 Children's Hopsital of Philadelphia Philadelphia Pennsylvania United States 19104
    13 St. Jude Children's Research Hospital Memphis Tennessee United States 38105
    14 Baylor College of Medicine Houston Texas United States 77030

    Sponsors and Collaborators

    • University of North Carolina, Chapel Hill
    • National Institute on Drug Abuse (NIDA)
    • National Institute of Mental Health (NIMH)

    Investigators

    • Study Chair: Amanda E Tanner, PhD, MPH, University of North Carolina, Greensboro
    • Study Chair: J. Dennis Fortenberry, MD, MS, Indiana University School of Medicine

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    None provided.
    Responsible Party:
    University of North Carolina, Chapel Hill
    ClinicalTrials.gov Identifier:
    NCT02785302
    Other Study ID Numbers:
    • ATN 135
    First Posted:
    May 27, 2016
    Last Update Posted:
    Feb 28, 2017
    Last Verified:
    Dec 1, 2016
    Keywords provided by University of North Carolina, Chapel Hill

    Study Results

    No Results Posted as of Feb 28, 2017